Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sana Biotechnology Inc
(NQ:
SANA
)
3.660
+0.160 (+4.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sana Biotechnology Inc
< Previous
1
2
3
4
Next >
The Top 3 Biotech Stocks to Watch in 2023
April 20, 2023
Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023.
Via
InvestorPlace
Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with Four Presentations at the 2023 AACR Annual Meeting
April 19, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher?
April 17, 2023
Good news drove shares of these stocks through the roof last week, but investors should be more concerned about their paths forward.
Via
The Motley Fool
Why Shares of Sana Biotechnology Jumped This Week
April 14, 2023
The company announced details of research on two of its pre-clinical therapies.
Via
The Motley Fool
Why Sana Biotechnology Shares Are Trading Higher Today
April 13, 2023
Sana Biotechnology (NASDAQ: SANA) shares are trading higher after the company announced the publication of a paper in Nature Communications on hypoimmune-modified allogeneic CD19-directed CAR T cells.
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for Sana Biotechnology: Here's What You Need To Know
January 24, 2023
Via
Benzinga
Sana Biotechnology Outlines Pipeline Prioritization, Reduces Workforce
November 30, 2022
Via
Benzinga
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 13, 2023
Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.
Via
Benzinga
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
April 13, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses
April 13, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Preclinical Data Published in Science Translational Medicine Showing its Hypoimmune Pancreatic Islet Cells Evaded Allogeneic and Autoimmune Rejection and Controlled Type 1 Diabetes in Preclinical Model
April 12, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces the Appointment of Two Pioneers in Drug Discovery and Development to Lead its R&D Organization
April 10, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
March 16, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces the Acceptance of Four Abstracts for Presentation at the 2023 American Association for Cancer Research Annual Meeting
March 14, 2023
Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene delivery to resting primary T cells
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference
February 02, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
January 26, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
December 28, 2022
On Wednesday, 258 companies hit new 52-week lows.
Via
Benzinga
Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual Meeting
December 11, 2022
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
December 19, 2022
On Monday, 297 companies reached new 52-week lows.
Via
Benzinga
Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio Prioritization
November 29, 2022
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
November 15, 2022
U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Sana Biotechnology Tops BioSpace’s 2023 Best Places to Work Ranking in Small Employer Category
November 14, 2022
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th American Society of Hematology Annual Meeting
November 03, 2022
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Reports Third Quarter 2022 Financial Results and Business Updates
November 02, 2022
From
Sana Biotechnology, Inc
Via
GlobeNewswire
7 Unknown Biotech Stocks That Could Rocket in 2023
September 23, 2022
Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.
Via
InvestorPlace
7 Stocks Due for a Stunning Short Squeeze
August 09, 2022
If you can handle the heat, these ideas could potentially cook up some massive profits.
Via
InvestorPlace
DocuSign CEO Shuffle: Why One Analyst Remains On The Sidelines For Now
June 22, 2022
After a horrendous year for Docusign Inc (NASDAQ: DOCU), the company made a major announcement this week that CEO Dan Springer will be stepping down.
Via
Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
July 25, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.